To summarize the epidemiological evidence and assess the validity of claimed associations of inflammatory bowel diseases (IBD) with overall and site-specific cancer risk.
To summarize the epidemiological evidence and assess the validity of claimed associations of inflammatory bowel diseases (IBD) with overall and site-specific cancer risk.